New patent expiration for Boehringer Ingelheim drug COMBIVENT RESPIMAT

Annual Drug Patent Expirations for COMBIVENT+RESPIMAT Combivent Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…

The post New patent expiration for Boehringer Ingelheim drug COMBIVENT RESPIMAT appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.